The aim of our study was to improve knowledge on the post-hypoxic cellular risks associated with OSA, as well as to better understand the cellular and molecular mechanisms that would be involved during repeated hypoxia, such as the HIF-1 pathway. The gene discussed is SETD2; the disease is obstructive sleep apnea syndrome.